Erowid References Database
|
Ashton CH, Moore PB, Sumnall H.
“Regulation of synthetic cannabinoids”.
Lancet. 2009 Nov 09;374(9701):1595.
|
|
Abstract
Greta McLachlan Aug 22, p 6001
comments on the recommendation
of the UK’s Advisory Council for
the Misuse of Drugs that synthetic
cannabinoids should be reclassifi ed
because they are without a medical
use.
We disagree that synthetic cannabinoids
“do not have a recognised
medical use”. The British National
Formulary2 lists nabilone a synthetic
analogue of tetrahydrocannabinol as
a prescription-only medicine available
for “nausea and vomiting caused by
cytotoxic chemotherapy, unresponsive
to other anti-emetics”. Other clinical
uses of cannabis and its derivatives
are described in the British Medical
Association book Therapeutic Uses of
Cannabis.3
|
| # |
| Submit Comment |
|
[
Cite HTML ]
